Bringing the Oncology Community Together

OncLive Announces 2013 “Giants of Cancer Care”

Press Release
Published Online: Friday, July 26, 2013
Oncology Luminaries Selected by Peers for Prestigious National Honor

PLAINSBORO, N.J. -- OncLive today announced the 2013 “Giants of Cancer Care,” 12 luminaries selected by oncology industry peers for their remarkable achievements in research and/or clinical practice. The inaugural Giants of Cancer Care awards recognize and celebrate individuals who have achieved landmark success within the field of oncology.

The Giants program is presented by OncLive, the official website for Oncology & Biotech News, OncologyLive, Urologists in Cancer Care, Oncology Nursing News, and Contemporary Oncology. Giants are organized by specialty and chosen by an exclusive advisory panel of oncology educators, clinicians and researchers.

OncLive Chairman and CEO Mike Hennessy said, “We’re proud to honor these exemplary members of the oncology profession. These ‘Giants’ have dedicated their lives to improving the quality and quantity of life for cancer patients. Our enormous gratitude is the foundation of this program.”

In evaluating criteria for selection to the inaugural class of Giants, the Advisory Panel considered “pioneers,” characterized by individuals who have amassed a large body of work and have already accomplished their most notable contributions to oncology; and separately, “innovators,” those who recently (within approximately the past 10 years) have made a significant contribution to patient care, clinical trials or translational research.

The 2013 Giants of Cancer Care

Breast: Bernard Fisher, M.D., University of Pittsburgh

Pioneer in the biology and treatment of breast cancer

Gastrointestinal: Bert Vogelstein, M.D., Johns Hopkins Medicine

Pioneer who discovered the molecular basis of colorectal cancer

Genetics: Elizabeth H. Blackburn, Ph.D., University of California, San Francisco

Innovator in the genetic composition and function of telomeres

Genitourinary: Lawrence H. Einhorn, M.D., Indiana University

Pioneered a life-saving treatment for testicular cancer

Head & Neck: Everett E. Vokes, M.D., University of Chicago

Innovator of concomitant chemoradiation therapy for head and neck cancers

Leukemia: Brian J. Druker, M.D., Oregon Health & Sciences University

Innovator of targeted therapies for chronic myeloid leukemia

Lung: Thomas J. Lynch, Jr., M.D., Yale Cancer Center

Pioneered the use of molecular testing for EGFR mutations in lung cancer

Lymphoma: Vincent T. DeVita, Jr., M.D., Yale Cancer Center

Innovator of combination chemotherapy regimens for large-cell lymphomas

Melanoma: Steven A. Rosenberg, M.D., National Institutes of Health

Pioneered adoptive immunotherapy in melanoma

Myeloma: Robert A. Kyle, M.D., Mayo Clinic

Pioneer in myeloma research, treatment and education

Prostate: Charles L. Sawyers, M.D., Memorial Sloan-Kettering Cancer Center

Innovator of novel androgen-receptor inhibitor for treatment of advanced prostate cancer

Scientific Advances: Judah Folkman, M.D., Harvard Medical School (deceased)

Pioneer and Father of angiogenesis

The 2013 Giants of Cancer Care will be acknowledged at an invitation-only reception Friday, July 26 at the Hyatt Regency in Huntington Beach, California. Each Giant will be individually profiled in a November 2013 special edition of OncologyLive and prominently featured on

Related Articles
Hitting the Target: How Druker’s Persistence Helped Launch a New Mode of Attack
Take a prognosis of three years, multiply it by 10, and what do you get? A staggering improvement in the survival of patients with chronic myeloid leukemia (CML), and a crucial steppingstone on the road to the targeted treatment of cancer.
Giants of Cancer Care Nominations Deadline Extended to April 15
Esteemed Oncology Awards Program to Name Giants in 16 Distinct Categories
Folkman’s Legacy of Bold and Creative Thinking Endures
During the course of a 74-year life cut short by his sudden death in 2008, Folkman changed the world repeatedly with bold ideas that ranged from implantable pacemakers and subcutaneous birth control to an entirely new field of medical study: how diseases like cancer recruit blood vessels from the body via angiogenesis.
Most Popular Right Now
More Reading
External Resources

American Journal of Managed Care
Pharmacy Times
Physicians' Education Resource
Physician's Money Digest
Specialty Pharmacy Times
OncLive Resources

OncLive TV
Oncology Nurses
Web Exclusives

About Us
Advisory Board
Contact Us
Forgot Password
Privacy Policy
Terms & Conditions
Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-716-4747

Copyright OncLive 2006-2014
Intellisphere, LLC. All Rights Reserved.